Clinical Trial Update: Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults [Phase 4]

View source ↗

Summary

A Phase 4 study assesses a dose-reduction strategy for Bictegravir/Emtricitabine/Tenofovir Alafenamide in virologically suppressed adults with HIV, reporting sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: HIV Infections | Phase 4 | Status: COMPLETED